Vi Partners announces first close of its new CHF 150 million fund

The first close coincides with the 25th anniversary of Vi Partners, marking a quarter-century of continuous venture capital activity. Since its founding in 2001, Vi Partners has supported successive generations of entrepreneurs and contributed to the development of Switzerland as a leading hub for technology and healthcare innovation. 

Building on more than two decades of investment activity, the new fund will focus on Series A and early-stage investments across technology and healthcare. In technology, Vi Partners backs companies building mission-critical software and data-driven platforms across areas such as enterprise, AI, fintech, and industrial applications. In healthcare, the firm supports companies addressing material clinical and healthcare systems needs across biotech, medtech, and digital health. This strategy builds on experience as an early partner to category-defining companies, including AMAL Therapeutics, Kuros Biosciences, Araris Biotech and Oculis in healthcare, as well as technology leaders such as Nexthink, SumUp, and Unique. 

“Over the past 25 years, we have consistently focused on identifying and supporting teams with strong scientific and technological foundations with the ambition to build outstanding companies,” said Diego Braguglia, Managing Partner at Vi Partners. “This new fund allows us to continue applying a disciplined, long-term investment approach, grounded in deep sector expertise and close collaboration with entrepreneurs.” 

“With this fund, we are entering the next phase of our investment activity and look forward to partnering with founders building category-defining companies out of Switzerland and Europe,” said Olivier Laplace, Managing Partner at Vi Partners. “Our role is to be a committed, hands-on partner from the early stages onward, combining capital with experience, network, and long-term support.” 

Since the founding of Vi Partners in 2001, Switzerland’s innovation ecosystem has evolved significantly, driven by world-class academic institutions such as ETH Zurich and EPFL, a growing entrepreneurial culture, and increasing international visibility. ETH Zurich co-initiated Vi Partners and remains an investor in its historical fund. 

“Switzerland has developed into one of Europe’s leading innovation hubs, particularly in life sciences and AI- and software-driven technologies,” said Gaetano Zanon, Managing Partner at Vi Partners. “Vi Partners’ long-standing presence in this ecosystem, combined with a disciplined investment approach, provides a strong foundation to continue supporting ambitious companies in the years ahead.” 

Following this first closing, Vi Partners will now begin deploying capital from the fund. The firm expects to hold subsequent closings as the year progresses. 

➡️ Source: Vi Partners | 📸 Vi Partners